All-trans retinoic acid induces DU145 cell cycle arrest through Cdk5 activation

Eugene Lin1, Mei-Chih Chen, Chih-Yang Huang

  • 1Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan.

Abstract

Insights

All-trans retinoic acid (ATRA) inhibits prostate cancer cell growth by activating cyclin-dependent kinase 5 (Cdk5) and p27. This study explores ATRA

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • All-trans retinoic acid (ATRA), the active form of vitamin A, is known to induce growth arrest in various cancer cells.
  • Cyclin-dependent kinase 5 (Cdk5) activity is modulated by ATRA, and Cdk5 has been implicated in prostate cancer cell fate.
  • Previous research suggests Cdk5 plays a role in the biological behavior of prostate cancer cells.

Purpose of the Study:

  • To investigate the role of Cdk5 in ATRA-induced growth arrest of the castration-resistant prostate cancer cell line DU145.
  • To determine if ATRA up-regulates the Cdk inhibitor protein, p27, in a Cdk5-dependent manner.
  • To elucidate the molecular mechanisms underlying ATRA's anti-proliferative effects in prostate cancer.

Main Methods:

  • DU145 cells were treated with ATRA.
  • Assessed cell proliferation, cell cycle distribution, and protein expression of Cdk5 and p27.
  • Examined protein localization of Cdk5/p27 using immunocytochemistry.
  • Utilized a Cdk5 inhibitor and siRNA for Cdk5 knockdown to assess functional roles.

Main Results:

  • ATRA treatment significantly inhibited DU145 cell proliferation.
  • ATRA significantly increased p27 expression, mediated by Cdk5 up-regulation.
  • Cdk5 inhibition reversed ATRA-induced G1 phase arrest and proliferation inhibition.
  • ATRA treatment led to increased nuclear localization of p27, which was reduced by Cdk5 inhibition.

Conclusions:

  • ATRA induces growth inhibition in castration-resistant prostate cancer cells by activating the Cdk5/p27 pathway.
  • This finding enhances understanding of prostate cancer treatment strategies.
  • Potential implications for nutritional interventions in prostate cancer patient management.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.3K